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Background: Now with the new triple therapie options sus-
tained viral response rates increased very much in genotype 1
patients. This therapie is very suitable for Turkey because of dom-
inance of genotype1 inTurkey (∼95%).
Methods & Materials: HCV RNA isolated with magnetic par-
ticle technique and detected with Bosphore HCV Kit v2 on the
real-time PCR platform (Anatolia Biotechnology, Istanbul, Turkey).
HCV NS3 region (30 - 181 aa) has been analysed for telaprevir and
boceprevir resistance mutation after population based sequencing.
NS3 inhibitors resistance mutation determination by geno2pheno
drug resistance tool (coreceptor.bioinf.mpi-inf.mpg.de). The fold
change of NS3 inhibitors resistance mutation is based on the IC50
valuesof thedrugs for thedifferentmutations and thewild typeand
fold change cutoff was 1.2. Consensus sequence from strain HPC-
PLYPRE, HPCCGAA, HPCJCG, HPCHUMR, HPCCGS and AY051292 for
HCV genotype 1b and H77 for type 1a sequences has been used in
the resistance mutation analysis.
Results: We analysed 36 patients. HCV RNA from 6 different
proviencesof Turkey before beginning telaprevir treatment and
found in3 (8,3%)patient telaprevir resistance and in1 (2,8%)patient
boseprevir resistance.
Only telaprevir is now available in Turkey. All this 36 patients
are relapsed after ﬁrst pegylated interferon and ribavirin treatment
or treatment naive cirrhotic patients.
Table 1;Demographic features and results ofHCVNS3 inhibitors
resistance mutation analysis in the telaprevir started treatment
naive Turkish patients with chronic hepatitis C.
Characteristics Study group
Gender, M/F, n(%) 12 (33%)/24 (66%)
Age, median (range) 56.6 (25 - 76)
HCV RNA load, median (range), IU/ml 4.2 +E7 (33+E2 - 10+E9)
HCV genotype, n(%) 1b; 35 (97.2)
1a; 1 (2.8)
ALT, median (range), U/L 67 (16 - 202)
AST, median (range), U/L 49.7 (8 - 116)
NS3 inhibitors resistance, n(%) Telaprevir; 3 (8.3)
Boceprevir; 1 (2.8)
NS3 inhibitors resistance mutation Telaprevir
T54S
L155I
I132V
Boceprevir
R109K
NS3 inhibitors resistance mutation T54S; 1.9
fold change (fold change cutoff: 1.2) L155I; 4.3 - 16.4
I132V; 1.8
R109K; 1.2
Conclusion: Despite this resistance proﬁle all the patients HCV
RNA at the ﬁrst month of therapy were under 1000 IU/mL. We
will see clinical aspects of this resistance pattern at the end of the
therapy.
http://dx.doi.org/10.1016/j.ijid.2014.03.1367
Type: Poster Presentation
Final Abstract Number: 64.038
Session: Virology and Viral Infections (Non-HIV) II
Date: Saturday, April 5, 2014
Time: 12:45-14:15
Room: Ballroom
Molecular characterization of rotavirus in
diarrhoeic children 0-5 Years of age in Kano,
Nigeria
A. Wada-Kura
National Biotechnology Development Agency Abuja,
Abuja, Nigeria
Background: Rotavirus (RV) is the most common cause of
severe diarrhoeal illness in infants and young children 0-5 years of
age in both developing and developed countries. However, limited
data exist on rotavirus (RV) infection in Kano, North-Western
Nigeria. This Study was aimed at determining the prevalence
and genotyping of rotavirus among these children using Enzyme
Linked ImmunoSorbent Assay (ELISA) and Reverse Transcription-
Polymerase Chain Reaction (RT-PCR).
Methods & Materials: A total of 285 stool samples were col-
lected from infants and children 0-5 years of age, who reported
with diarrhea in six different hospitals in Kano, Nigeria between
November 2009 and July 2010. The diarrhoeic Stools were ana-
lyzed for RV antigen (ELISA), and theRVpositive stoolswere further
subjected to VP7 and VP4 genotyping using gene speciﬁc primers
(RT-PCR).
Results: Rotavirus was detected in 36.5% (104/285) of the diar-
rhoeic children. The infectionoccurred throughout the studyperiod
withhigherpeaks in thedriermonthofApril 77.6% (38/49) and low-
est in July 12.2% (5/41) (Pearson Chi Square analysis: X2= 27.720,
P <0.05, df = 1). The highest prevalence of RV infection was in chil-
dren 41-50 months 50% (3/6) The RV was detected more in male
37.2% (61/164) than female 35.4% (43/121) children and no statisti-
cally signiﬁcant difference was observed (P >0.05). Three different
rotavirus P-genotypes (P[8], P[4], and P[6]) were detected in this
study and P[6] (48.5%) was the most commonly detected. Mixed
infection were detected and consisted only of P[8] + P[6]. Six differ-
ent G-genotypes were detected. The predominant genotype was
G2 35.0% (36/103). The most common G and P combination was
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found to be G2P [6] with 19.4% (20/103) frequency of occurrence.
A single GNTP [8+6] mixed combination of rotavirus strains was
also detected during the study. Strains such as G6, G9 andG12were
also detected at very low levels.
Conclusion: Rotavirus was found to be an important cause of
diarrhoea in children 0-5 years of age in Kano, North-Western
Nigeria. Further characterization of RV strains circulating in the
study area is also needed to provide information needed for
implementation of RV vaccination and vaccine effectiveness stud-
ies.Rotavirus vaccination should be considered as part of routine
immunization in Nigeria.
http://dx.doi.org/10.1016/j.ijid.2014.03.1368
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Background: Chikungunya (CHIK) is a serious health issue in
India and exists as single or co-infections along with Dengue
(DENV). Initially restricted to the Southern parts of the country,
CHIK has spread to most of the country with 18 states/Union Terri-
tories of the 26 states/UTs affected currently. Thepresent studywas
conducted to understand the divergence of CHIKV from two parts
of the country - Mumbai, where the virus was in circulation since
a long time, and from Delhi, where the virus was witnessed since
2009. Clinical and genetic information of patients were compared
to comprehend the divergence and evolution of the virus within
the country.
Methods & Materials: Blood samples were collected over a
period of three years (2010-2012) from patients after obtaining
their consent and clinical information. Clinical correlationwas per-
formed within the two states. Dengue status was analysed with
respect to clinical manifestation of symptoms. RNA was extracted
from sera and partial gene of E1 envelope protein was ampliﬁed.
The PCR products were puriﬁed, sequenced and phylogenetic anal-
yses performed on the sequences.
Results: A total of 459 samples were collected over the period
of three years from the two states. Serosurveillance showed 68% of
patients to be positive for CHIKV IgM. Patients showed distinct dif-
ferences in restriction of joint movements in case of CHIK only and
CHIK/DENV co-infections. Platelet was another important feature
to distinguish between CHIK and CHIK/DENV co-infection. Genetic
characterisation of the samples revealed that all Indian samples
were of ECSA genotype and showing K211E mutation as reported
earlier showing the expansion and establishment of this sub-clade
since 2010. Further, several mutations were seen in selected sam-
ples which resulted in amino acid changes in the protein.
Conclusion: This study has thrown insights to the trend of
Chikungunya spread in India.Whole genome sequencing of the iso-
lates from the two states will provide important information with
respect to the virulence of the virus over the years.
http://dx.doi.org/10.1016/j.ijid.2014.03.1369
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Background: Enterovirus 71 (EV71) is a positive-stranded RNA
virus, belong to genus Enterovirus within the family Picornaviridae.
It is one of the common causative agent of hand-foot-and-mouth
disease (HFMD) and causes severe neurologic diseases such as
central never system (CNS) injury in infants. Although two EV71
receptors SCARB2 and PSGL-1 and several cell surface molecules
have been indicated facilitate the process of virus attachment dur-
ing the past few years, the mechanisms of EV71 early infection
remain unclear. Therefore, to discover the new factorswhichmedi-
ated the recognition or entry of EV71 should be an important issue
for evaluating the mechanisms of EV71 infection. Our previous
report demonstrated that sialylated surface proteins inﬂuence the
binding of EV71 to host cells. In this study,we applied the glycopro-
teomic approaches to identify EV71-associated glycoproteins that
may involve in the early phase of EV71 infection. We also evalu-
ated and veriﬁed the functions of candidate protein in EV71 virus
attachment.
Methods&Materials: Sialylated glycoproteinswere puriﬁedby
Glycan chromatography from the cell membrane extraction of RD
cells. The isolated glycoproteins were precipitated with EV71 viral
particles, and identiﬁcation by LC MS/MS analysis. The functions
of candidate protein were evaluated by virus binding assay and
infection assay.
Results: According to our results, we suggest that the candi-
date protein participates in EV71 virus attachment. EV71 binding
and virus entry markedly reduced after si-RNA silencing. Accord-
ing to our results, we suggest this candidate proteinwas a potential
receptor for EV71 infection.
Conclusion: We successfully apply new glycoproteomic
methodology to identify the EV71-associated glycoproteins and
indicated the candidate glycoprotein which facilitate the early
phase of virus infection. Our ﬁnding also contribute to understand-
ing the mechanisms of EV71 early infection and the therapeutic
drug development.
http://dx.doi.org/10.1016/j.ijid.2014.03.1370
